A new trading day began on Monday, with SpringWorks Therapeutics Inc (NASDAQ: SWTX) stock price down -4.48% from the previous day of trading, before settling in for the closing price of $37.50. SWTX’s price has ranged from $28.21 to $53.92 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -25.00%. Meanwhile, its annual earnings per share averaged 40.97%. With a float of $65.76 million, this company’s outstanding shares have now reached $74.34 million.
Let’s determine the extent of company efficiency that accounts for 305 employees. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.
SpringWorks Therapeutics Inc (SWTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of SpringWorks Therapeutics Inc is 11.59%, while institutional ownership is 102.79%. The most recent insider transaction that took place on Dec 03 ’24, was worth 839,336. In this transaction Chief Operating Officer of this company sold 20,000 shares at a rate of $41.97, taking the stock ownership to the 209,600 shares. Before that another transaction happened on Dec 02 ’24, when Company’s Chief Executive Officer sold 49,000 for $41.37, making the entire transaction worth $2,027,357. This insider now owns 1,014,368 shares in total.
SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 40.97% per share during the next fiscal year.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators
Here are SpringWorks Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 19.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -1.98 in one year’s time.
Technical Analysis of SpringWorks Therapeutics Inc (SWTX)
Looking closely at SpringWorks Therapeutics Inc (NASDAQ: SWTX), its last 5-days average volume was 0.98 million, which is a drop from its year-to-date volume of 1.71 million. As of the previous 9 days, the stock’s Stochastic %D was 54.99%. Additionally, its Average True Range was 2.52.
During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 43.64%, which indicates a significant decrease from 54.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 73.35% in the past 14 days, which was higher than the 56.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $38.01, while its 200-day Moving Average is $37.59. However, in the short run, SpringWorks Therapeutics Inc’s stock first resistance to watch stands at $36.80. Second resistance stands at $37.78. The third major resistance level sits at $38.48. If the price goes on to break the first support level at $35.12, it is likely to go to the next support level at $34.42. Should the price break the second support level, the third support level stands at $33.44.
SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats
With a market capitalization of 2.66 billion, the company has a total of 74,386K Shares Outstanding. Currently, annual sales are 5,450 K while annual income is -325,100 K. The company’s previous quarter sales were 49,300 K while its latest quarter income was -53,530 K.
